Most MS Patients Who Received Stem Cell Transplants Still in Remission 3 … – Healthline
Healthline |
Most MS Patients Who Received Stem Cell Transplants Still in Remission 3 …
Healthline Three years after the stem cell study HALT-MS began, many of the multiple sclerosis (MS) patients who took part are still in remission. The phase 2 study has demonstrated impressive results by rebuilding the immune system using a patient's own stem cells. |
